Brief: Pulmonx Receives Japanese Approval Of Severe Copd/Emphysema Treatment
30/11/2022 12:39
Nov 30 (Reuters) - Pulmonx Corp LUNG.O :
* PULMONX RECEIVES JAPANESE MHLW APPROVAL OF ZEPHYR
ENDOBRONCHIAL
VALVE FOR TREATMENT OF SEVERE COPD/EMPHYSEMA
Source text for Eikon: ID:nBwb7b3vca
Further company coverage: LUNG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmonx
See all newsBrief: Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Pulmonx Corp reports results for the quarter ended June 30 - Earnings Summary
Pulmonx Corp Q2 revenue falls, but beats estimates
Brief: Pulmonx Q2 EPS USD -0.24
Pulmonx Corp expected to post a loss of 28 cents a share - Earnings Preview